94184 ⎘
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms Oxygen atoms
Sub-classes:Synthesis of GLP-1R/GIPR Agonists and Precursors Thereof
#2IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF
#3TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
#4METHODS OF TREATING CANCER
#5C3-CARBON LINKED GLUTARIMIDE DEGRONIMERS FOR TARGET PROTEIN DEGRADATION
#6SMALL MOLECULE COMPOUNDS TARGETING SRSF6 PROTEIN AND THEIR PREPARATION METHODS AND APPLICATIONS
#7Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#8INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY
#9IONIZABLE LIPIDS AND COMPOSITIONS AND USES THEREOF
#10SMALL MOLECULE RPN13 INHIBITORS WITH ANTITUMOR PROPERTIES
#11Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
#12Methods of treating cancer
#13C-carbon linked glutarimide degronimers for target protein degradation
#14Ionizable compounds and compositions and uses thereof
#15Piperlongumine-based compound and immuno regulator comprising the same
#16PROLYL HYDROXYLASE INHIBITORS
#171',3'-Disubstituted-4-Phenyl-3,4,5,6-Tetrahydro-2H,1'H-[1,4']Bipyridinyl-2'-Ones
#18Inhibitors of the WNT/beta-catenin pathway
#19Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
#20Derivatives of piperlongumine and uses thereof
#21ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
#22Crystal forms of oxypyridine amide derivative and preparation method therefor
#23Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#24METHODS OF TREATING CANCER
#25Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols
#261′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones
#27Substituted glycine derived FXIA inhibitors
#28Anti-fibrotic pyridinones
#29Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#30Methods for enantioselective allylic alkylation of esters, lactones, and lactams with unactivated allylic alcohols
#31Ionizable compounds and compositions and uses thereof
#32METHODS OF TREATING CANCER
#33C3-carbon linked glutarimide degronimers for target protein degradation
#34Prolyl hydroxylase inhibitors
#35BROMODOMAIN INHIBITORS
#36METHODS OF TREATMENT USING PYRIDINONYL PDK1 INHIBITORS
#37Process for the preparation of apixaban and intermediates thereof
#38Non-aromatic heterocyclic derivative having MGAT2 inhibitory activity
#39Pyridone compounds and agricultural and horticultural fungicides containing said compounds as active ingredient
#40Small molecule stimulators of steroid receptor coactivator proteins and their use in the treatment of cancer
#41Process for the preparation of dolutegravir
#42Substituted glycine derived FXIA inhibitors
#43Enhancer of Zeste Homolog 2 inhibitors
#44Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#45Compounds and methods for the treatment of neurodegenerative diseases
#46Process for the preparation of Apixaban and intermediates thereof
#47Anti-fibrotic pyridinones
#48Kinase inhibitors
#49Process for the preparation of Apixaban and intermediates thereof
#50METHODS OF TREATING CANCER
#51METHODS OF TREATING CANCER
#52PROLYL HYDROXYLASE INHIBITORS
#53Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#54Fluorinated derivatives of 3-hydroxypyridin-4-ones
#55Process for the preparation of apixaban and intermediates thereof
#56PIPERIDINE-DIONE DERIVATIVES
#57Kinase inhibitors
#58Ionizable compounds and compositions and uses thereof
#59Bromodomain inhibitors
#60Anti-fibrotic pyridinones
#61PHOTOPROTECTIVE COMPOUNDS, COMPOSITIONS INCLUDING SAME AND USES THEREOF
#62Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#63Intermediate and polymorphs of 1-(4-methoxypheny1)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetra hydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and process thereof
#64Substituted (3S,11AR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11A-hexahydro[1,3]oxazolo[3,2-A]pyrido[1,2-D]pyrazine-8-carboxamides as HIV agents
#65Fluorinated derivatives of 3-hydroxypyridin-4-ones
#66SYNTHESIS OF UV ABSORBING COMPOUNDS
#67Prolyl hydroxylase inhibitors
#68Bromodomain inhibitors
#69CYSTEINE AND CYSTINE PRODRUGS TO TREAT SCHIZOPHRENIA AND REDUCE DRUG CRAVINGS
#70Bromodomain inhibitors
#71Methods for increasing the stabilization of hypoxia inducible factor-α
#72Dihydropyridin-2(1H)-one compounds as -nitrosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
#73Enhancer of zeste homolog 2 inhibitors
#74Heterocyclic compound
#75Apixaban preparation process
#76Methods of treatment using pyridinonyl PDK1 inhibitors
#77Dihydropyridinone MGAT2 inhibitors
#78N-link hydroxamic acid derivatives useful as antibacterial agents
#79Kinase inhibitor
#80Kinase inhibitors
#812-(2-hydroxy-2-phenylethyl)-3-[(phenylmethyl)oxy]-4H-pyran-4-one of the formula P-3 and/or 2-[(E)-2-phenylethenyl]-3-[(phenylmethyl)oxy]-4H-Pyran-4-one of the formula P-4
#82Substituted (3S, 11aR)-N-[(2,4-difluorophenyl)methyl]-6-oxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydro[1,3]oxazolo[3,2-a]pyrido[1,2-d]pyrazine-8-carboxamides of formula (I) useful as HIV agents
#83Methods of treating cancer
#84N-link hydroxamic acid derivatives useful as antibacterial agents
#85Anti-fibrotic pyridinones
#86Apixaban preparation process
#874-oxo-3-[(phenylmethyl)oxy]-4H-pyran-2-carboxylic acid
#881-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylic acid of the formula P-6 and/or methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate of the formula P-7
#89Compounds, compositions, and methods for cancer therapy
#901′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro--[1,4′]bipyridinyl-2′-ones
#911',3'-DISUBSTITUTED-4-PHENY-3,4,5,6-TETRAHYDRO-2H,1'H-[1,4']BIPYRIDINYL-2'-ONES
#92Dihydropyridin-2(1H)-one compound as S-nirtosoglutathione reductase inhibitors and neurokinin-3 receptor antagonists
#93SUBSTITUTED 3-PIPERIDONE COMPOUNDS
#94Inhibitors of catechol O-methyl transferase and their use in the treatment of psychotic disorders
#95Fluorinated derivates of 3-hydroxypyridin-4-ones
#96N-linked hydroxamic acid derivatives useful as antibacterial agents
#97Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
#98Compounds And Compositions For Treating Cancer
#99Compounds and compositions for treating cancer
#100ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE
#1011-heterodiene derivative and harmful organism control agent
#102Thalidomide analogs
#103Methyl 3-(benzyloxy)-1-(2,2-dihydroxyethyl)-4-oxo-1,4-dihydropyridine-2-carboxylate and processes for the preparation thereof
#104Glucose metabolism modulating compounds
#105Compositions and methods for treating colitis
#106Methods for increasing the stabilization of hypoxia inducible factor-1 alpha
#107Prolyl hydroxylase inhibitors
#108Compounds and compositions for treating cancer
#109Novel 2-Oxo-Heterocyclic Compounds And The Pharmaceutical Compositions Comprising The Same
#1101′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-[1,4′] bipyridinyl-2′-ones
#111Dihydropyridone amidesas P2Xmodulators
#112Dihydropyridone ureas as P2Xmodulators
#113Dihydropyridone amides as P2X7 modulators
#114Pyridinonyl PDK1 inhibitors
#115Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#116Abnormal cannabidiols as agents for lowering intraocular pressure
#1172-Amino-7,8-dihydro-6H-pyrido[4,3-D]pyrimidin-5-ones
#118METHODS FOR THE TREATMENT OF CANCER USING PIPERLONGUMINE AND PIPERLONGUMINE ANALOGS
#119Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
#120Cyclic derivatives as modulators of chemokine receptor activity
#121Heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
#122Nitrogen-Containing Heterocyclic Compounds and Medicinal Use Thereof
#123NOVEL HERBICIDES
#124Abnormal Cannabidiols as agents for lowering intraocular pressure
#125Abnormal cannabidiols as agents for lowering intraocular pressure
#1262-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
#127Vanilloid receptor ligands and their use in treatments
#1282-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-ones
#129Cyclic derivatives as modulators of chemokine receptor activity
#130SYNTHESIS OF 4,5-DIHYDRO-PYRAZOLO[3,4-C]PYRID-2-ONES
#131Thalidomide analogs
#132O-coordinated metal chelates and their use in optical recording media having high storage capacity
#1332-oxo-heterocyclic compounds and pharmaceutical compositions
#134Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#135Aromatic sulfone hydroxamic acid metalloprotease inhibitor
#136Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
#1372,3-dihydro-4(1H)-pyridone derivatives , method for production thereof and pharmaceutical composition comprising the same
#138Substituted aryl thioureas and related compounds; inhibitors of viral replication
#139Metabolites of (+)-(2S,3S)-3(2-methoxy-5- trifluoromethoxybenzylamino)-2-phenyl-piperidine
#140Synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
#141Herbicides
#142Herbicides
#143Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
#144Cyclic derivatives as modulators of chemokine receptor activity
#145Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinone
#146Nitrogeneous cyclic ketone derivative, process for producing the same, and use